A novel device (SD-101) with high accuracy for screening sleep apnoea-hypopnoea syndrome

被引:31
|
作者
Agatsuma, Toshihiko [1 ]
Fujimoto, Keisaku [1 ]
Komatsu, Yoshimichi [1 ]
Urushihata, Kazuhisa [1 ]
Honda, Takayuki [2 ]
Tsukahara, Teruomi [3 ]
Nomiyama, Tetsuo [4 ]
机构
[1] Shinshu Univ, Sch Med, Dept Internal Med 1, Nagano 3908621, Japan
[2] Shinshu Univ, Sch Med, Dept Lab Med, Nagano 3908621, Japan
[3] Shinshu Univ, Sch Med, Ctr Hlth Safety & Environm Management, Nagano 3908621, Japan
[4] Shinshu Univ, Sch Med, Dept Prevent Med & Publ Hlth, Nagano 3908621, Japan
关键词
polysomnography; portable device; pressure sensor array; screening; sleep apnoea syndrome; POSITIVE AIRWAY PRESSURE; POLYSOMNOGRAPHY; MEN;
D O I
10.1111/j.1440-1843.2009.01627.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: The SD-101 is a non-restrictive, sheet-like medical device with an array of pressure sensors, to detect sleep-disordered breathing by sensing gravitational alterations in the body corresponding to respiratory movements. This study evaluated the accuracy of the SD-101 for screening sleep apnoea-hypopnoea syndrome (SAHS) by comparison with polysomnography. Methods: Nocturnal polysomnography and SD-101 monitoring were conducted simultaneously and compared in 201 patients with suspected SAHS (suspected SAHS group) and 165 male employees of a transport company (screening group). Results: Polysomnography revealed an AHI of <5, 5 <= AHI < 15, 15 <= AHI < 30, 30 <= AHI < 60 and AHI >= 60 events/h in 39, 35, 38, 68 and 21 subjects in the suspected SAHS group and 103, 34, 12, 12 and four subjects in the screening group, respectively. Central SAHS and obstructive SAHS were subsequently diagnosed in 11 (5.5%) and 135 (67.2%) of subjects in the suspected SAHS group and five (3.0%) and 39 (23.6%) of subjects in the screening group, respectively. Significant correlations were apparent between AHI and the respiratory disturbance index (RDI) measured with the SD-101 in both the suspected SAHS group (r = 0.88) and screening group (r = 0.92). Receiver operating characteristic curve analysis revealed 89.5% sensitivity and 85.8% specificity in identifying SAHS, using an RDI of 14.0 events/h. Conclusions: These findings suggest that the SD-101 is a useful device for screening SAHS.
引用
收藏
页码:1143 / 1150
页数:8
相关论文
共 50 条
  • [31] Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome
    Riha, Renata L.
    Diefenbach, Konstanze
    Jennum, Poul
    McNicholas, Walter T.
    [J]. SLEEP MEDICINE REVIEWS, 2008, 12 (01) : 49 - 63
  • [32] Pattern recognition in airflow recordings to assist in the sleep apnoea-hypopnoea syndrome diagnosis
    Gutierrez-Tobal, Gonzalo C.
    Alvarez, Daniel
    Victor Marcos, J.
    del Campo, Felix
    Hornero, Roberto
    [J]. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2013, 51 (12) : 1367 - 1380
  • [33] Sleep Minder: An Innovative Contact-Free Device for the Estimation of the Apnoea-Hypopnoea Index
    Zaffaroni, Alberto
    de Chazal, Philip
    Heneghan, Conor
    Boyle, Patricia
    Ronayne, Patricia
    McNicholas, Walter T.
    [J]. 2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-20, 2009, : 7091 - +
  • [34] Obstructive sleep apnoea-hypopnoea syndrome reversibly depresses cardiac response to exercise:: reply
    Alonso-Fernandez, Alberto
    Garcia-Rio, Francisco
    Arias, Miguel A.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (13) : 1633 - 1634
  • [35] Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea-hypopnoea syndrome
    Chiner, E
    Arriero, JM
    Signes-Costa, J
    Marco, J
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (02) : 313 - 315
  • [36] A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome
    McDaid, Catriona
    Duree, Kate H.
    Griffin, Susan C.
    Weatherly, Helen L. A.
    Stradling, John R.
    Davies, Robert J. O.
    Sculpher, Mark J.
    Westwood, Marie E.
    [J]. SLEEP MEDICINE REVIEWS, 2009, 13 (06) : 427 - 436
  • [37] Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome
    Garcia de Lucas, M. D.
    Olalla Sierra, J.
    Pina Fernandez, J.
    [J]. DIABETES & METABOLISM, 2015, 41 (01) : 102 - 103
  • [38] THE EFFECT OF OBESITY ON DETECTION RATE OF OBSTRUCTIVE SLEEP APNOEA-HYPOPNOEA SYNDROME IN HYPERTENSIVE PATIENTS
    Zhang Li-li
    Yan Zhi-tao
    Han Rui-mei
    Cheng Wei-ping
    Li Nanfang
    [J]. HEART, 2012, 98 : E256 - E256
  • [39] Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome
    Dingli, K
    Coleman, EL
    Vennelle, M
    Finch, SP
    Wraith, PK
    Mackay, TW
    Douglas, NJ
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (02) : 253 - 259
  • [40] Identifying sleep apnoea-hypopnoea syndrome in the cardiovascular risk consultation: assessing the why and the how
    Torres Cortada, Gerard
    Sacristan Garcia, Oscar
    [J]. HIPERTENSION Y RIESGO VASCULAR, 2018, 35 (01): : 1 - 4